EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Elucidation of DNA Primase as a Drug Target in Leishmania donovani : Structure‐Guided Inhibitor Identification and Biochemical Validation

Deep Bhowmik iD, Anupama Sharma iD, Ravi Prakash Arya iD, Diwakar Kumar iD

Chemical Biology & Drug Design · 2026-07 · 108 (1)

DOI: 10.1111/cbdd.70362 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2026-07-25. Written by Deep Bhowmik and 3 co-authors. Institution: Department of Microbiology, Assam University, Silchar, Assam, India. Major MEDLINE topics: Leishmania donovani, DNA Primase, Enzyme Inhibitors, Antiprotozoal Agents. 103 references. The full text is freely available (open access, CC BY 4.0). Funded by: Anusandhan National Research Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Replication is started by DNA primase, which synthesizes an oligoribonucleotide primer that DNA polymerases extend. Effective chemotherapy is still needed to manage and treat leishmaniasis, which continues to pose a threat to public health around the world. Repurposing drugs offers alternative uses for drugs with established pharmacological effects, saving money and increasing the pool of human resources available to create novel anti‐leishmanials. Here, we used a non‐radioactive primase‐pyrophosphatase assay to biochemically characterize the Leishmania donovani nuclear DNA primase ( LdPri ) subunits, followed by in silico evaluation of inhibitors targeting LdPri . The best‐evaluated inhibitors showed LdPri inhibition in vitro under conditions similar to those of the primase‐pyrophosphatase experiment. The MTT assay also confirmed the inhibitors' anti‐leishmanial properties. Parasite growth and morphological analysis were performed by culturing cells in the presence of inhibitors. Biochemical characterization revealed that LdPriS activity was unstable, but was highly stabilized upon association with LdPriL in LdPri . LdPri was found to be thermostable and possesses 3′‐terminal nucleotidyltransferase activity. Additionally, in silico and in vitro studies evaluated Pritelivir (BAY 57‐1293) as the most efficient LdPri complex inhibitor, followed by Epigallocatechin Gallate (EGCG). Moreover, kinetic studies showed that Pritelivir and EGCG exhibit competitive and uncompetitive inhibition, respectively, for both NTP and DNA substrates. Pritelivir effectively disrupted the L. donovani cell cycle, and the replication mechanism in treated promastigotes showed irregular shapes and short flagella.

Subjects

MeSH terms (MEDLINE)

Leishmania donovaniDNA PrimaseEnzyme InhibitorsAntiprotozoal AgentsMolecular Docking SimulationHumansCatechin

Author keywords

DNA primaseMTT assaysenzyme inhibitioninhibitorsleishmaniasisprimase‐pyrophosphatase assay

Substances

DNA PrimaseEnzyme InhibitorsAntiprotozoal AgentsCatechinepigallocatechin gallate

Authors and institutions

  • Department of Microbiology, Assam University, Silchar, Assam, India.
  • Department of Veterinary Microbiology, Assam Veterinary and Fishery University, Khanapara, Guwahati, India.
  • Center for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad, India.
  • Department of Biotechnology, Assam University, Silchar, Assam, India.

ORCID profiles: Deep Bhowmik, Anupama Sharma, Ravi Prakash Arya, Diwakar Kumar

Funding

  • Anusandhan National Research Foundation

Cite

APA

Bhowmik, D., Sharma, A., Arya, R. P., & Kumar, D. (2026). Elucidation of DNA Primase as a Drug Target in Leishmania donovani : Structure‐Guided Inhibitor Identification and Biochemical Validation. Chemical Biology & Drug Design, 108(1). https://doi.org/10.1111/cbdd.70362

Vancouver

Bhowmik D, Sharma A, Arya RP, Kumar D. Elucidation of DNA Primase as a Drug Target in Leishmania donovani : Structure‐Guided Inhibitor Identification and Biochemical Validation. Chemical Biology & Drug Design. 2026;108(1). doi:10.1111/cbdd.70362

BibTeX
@article{Bhowmik2026,
  author = {Bhowmik, Deep and Sharma, Anupama and Arya, Ravi Prakash and Kumar, Diwakar},
  title = {Elucidation of DNA Primase as a Drug Target in Leishmania donovani : Structure‐Guided Inhibitor Identification and Biochemical Validation},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {108},
  number = {1},
  doi = {10.1111/cbdd.70362}
}
Start for free →